Serum adiponectin levels correlate strongly with non-alcoholic steatohepatitis (NASH) grade and fibrosis stage in non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Savvidou, Savvoula
Goulis, John
Hytiroglou, Prodromos
Orfanou-Koumerkeridou, Eleni
Frantzoulis, Peggy
Panderis, Athanasia
Arvanitakis, Constantine
机构：
[1] Hippocration Gen Hosp, Dept Internal Med 4, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, Thessaloniki, Greece
[3] Hippocration Gen Hosp, Dept Internal Med 2, Lab Clin Immunol & Hepatol, Thessaloniki, Greece
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1219
引用
收藏
页码：644A / 644A
页数：1
相关论文
共 50 条
  • [41] A National Survey of Physicians Regarding Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH): The Disease and Clinical Trial Awareness Program for NASH
    Younossi, Zobair M.
    Stepanova, Maria
    Saenz, Thomas
    Cooper, Gayle
    Schmidt, Christa
    Petruccelli, Steve
    HEPATOLOGY, 2017, 66 : 1184A - 1184A
  • [42] PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
    Peyrou, Marion
    Bourgoin, Lucie
    Foti, Michelangelo
    DIGESTIVE DISEASES, 2010, 28 (01) : 236 - 246
  • [43] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279
  • [44] An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 759 - 772
  • [45] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [46] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
    Daher, Saleh
    Cohen, Namma Lev
    Massarwa, Muhammad
    Mahamid, Mahmud
    Nasser, Mira
    Hazou, Wadi
    Oren, Rani
    Safadi, Rifaat
    Khoury, Tawfik
    PLOS ONE, 2018, 13 (11):
  • [47] Serum Obestatin Concentrations in Non-Alcoholic Fatty Liver Disease (NAFLD) With Fibrosis
    Estep, Michael
    Abawi, Massihulla
    Bolden, Shanna
    Stepanova, Maria
    Hossain, Noreen
    Goodman, Zachary
    Chandhoke, Vikas
    Baranova, Ancha
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2010, 138 (05) : S802 - S802
  • [48] Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)
    Amaro, R
    Montalbano, M
    Acosta, RC
    Concha, R
    Weppler, D
    Neff, GW
    O'Brien, CB
    Molina, EG
    Schiff, ER
    Tzakis, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A118 - A118
  • [49] LDL:HDL Ratio as a Risk Factor for Non-Alcoholic Steatohepatitis (NASH) in Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S544 - S545
  • [50] Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Bifari, Francesco
    Manfrini, Roberto
    Cas, Michele Dei
    Berra, Cesare
    Siano, Matteo
    Zuin, Massimo
    Paroni, Rita
    Folli, Franco
    PHARMACOLOGICAL RESEARCH, 2018, 137 : 219 - 229
12345